MULTIPLE ENDOCRINE ABNORMALITIES OF THE GROWTH-HORMONE AND INSULIN-LIKE-GROWTH-FACTOR AXIS IN PREPUBERTAL CHILDREN WITH EXOGENOUS OBESITY -EFFECT OF SHORT-TERM AND LONG-TERM WEIGHT-REDUCTION
J. Argente et al., MULTIPLE ENDOCRINE ABNORMALITIES OF THE GROWTH-HORMONE AND INSULIN-LIKE-GROWTH-FACTOR AXIS IN PREPUBERTAL CHILDREN WITH EXOGENOUS OBESITY -EFFECT OF SHORT-TERM AND LONG-TERM WEIGHT-REDUCTION, The Journal of clinical endocrinology and metabolism, 82(7), 1997, pp. 2076-2083
We have studied the GH-insulin-like growth factor (IGF) axis in prepub
ertal children with exogenous obesity at the time of clinical diagnosi
s and at two time points during weight reduction on a calorie-restrict
ed diet. Spontaneous GH secretion, IGF-I, free IGF-I (fIGF-I), IGF-II,
their binding proteins (IGFBP-1, IGFBP-2, and IGFBP-3), and GH-bindin
g protein (GHBP) values at the time of clinical diagnosis (n = 65), af
ter a 25% decrease in the body mass index (BMI) expressed as the so sc
ore (BMI so score; n = 29), and after a diminution of at least 50% of
the the initial BMI so score (n = 9) are reported. GH secretion was si
gnificantly reduced at diagnosis, and after a decrease of at least 25%
in the initial BMI so score, it returned to normal in all patients. T
otal IGF-I levels were not significantly different from those in contr
ols at any point. In contrast, fIGF-I and IGF-II levels were significa
ntly increased, both at diagnosis and after BMI so score reduction. Ob
ese patients were hyperinsulinemic at diagnosis and remained so even a
fter a 50% reduction of their BMI SD score. Serum IGFBP-1 and IGFBP-2
levels were significantly decreased at diagnosis and at the two points
studied during weight reduction. Serum IGFBP-3 and GHBP levels were i
ncreased significantly at diagnosis and returned to normal levels afte
r a reduction in the BMI so score. A positive correlation between seru
m GHBP levels and BMI was found in both controls and obese patients. S
erum IGFBP-3 levels correlated positively with IGF-I, fIGF-I, and IGF-
II in all groups, but these correlations were weaker in the obese pati
ents at diagnosis. IGFBP-2 correlated significantly with IGF-II only i
n the obese group at diagnosis (r = -0.760; P < 0.0001), but with fIGF
-I in all groups. IGFBP-1 was negatively correlated with IGF-I and fIG
F-I in all groups. In conclusion, the GH-IGF axis is dramatically alte
red in patients with exogenous obesity. However, most changes in the p
eripheral IGF system appear to be independent of the modifications in
GH secretion. In addition, in contrast to current thought, not all of
the observed abnormalities are reversed with a significant reduction i
n the BMI so score.